Related Experiment Video
Updated: May 13, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
[Trends and predictions of tuberculosis, and challenges towards tuberculosis eradication in Havana City]
Alexander González Díaz1, Lizet Sánchez Valdés, Luisa Armas Pérez
1Instituto de Medicina Tropical "Pedro Kourí", La Habana, Cuba.
Objectives:
To describe the variation and the trend of new tuberculosis case reports in Havana from 1995 to 2010, as well as their projection and occurrence for 2011-2013.
Methods:
A time series study was conducted, and the annual total and mean variation percentages of rates by clinical and bacteriological categories, age, municipal distribution and TB/HIV co-infection were analyzed. Estimation of projections by using two-parameter exponential smoothing techniques was made.
Results:
The rate of new reported TB cases decreased from 16.8 in 1995 to 9.5 per 100 000 inhabitants in 2010 (43.5% and 2.9% of annual total variation and mean variation respectively). The rate declined by 80% in the municipalities and in 15-64 and > or = 65 years age groups. Habana Vieja and Centro Habana municipalities kept the highest rates throughout the whole period. TB/HIV coinfection notification increased from 3 out of 369 (0.8%) cases in 1995 to 37 out of 202 (18.3%) cases in 2010. A slight increase was estimated for the 2011-2013 period (9.5; 10.0; 10.5 per 100 000 population respectively) in addition to continuous rise of the number of cases with TB/HIV co-infection.
Conclusions:
The TB trend showed a steady decline in Havana from 1995 to 2010, with substantial reduction in the study period, except for TB/HIV co-infection in which the number of cases increases. The TB case report rates are within the expected values, although slightly above the predictions.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Principles of Disease Surveillance